Literature DB >> 8780088

Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men.

D M Morens1, J W Davis, A Grandinetti, G W Ross, J S Popper, L R White.   

Abstract

We determined age-specific and age-adjusted incidence rates and mortality rates of idiopathic Parkinson's disease (PD) in a cohort of men followed for 29 years. Since enrollment in 1965, the Honolulu Heart Study has followed 8,006 American men of Japanese or Okinawan ancestry. Rescreening of the entire cohort, completed in 1994, included attempts to detect all prevalent and incident cases of PD, parkinsonism, and related conditions. PD incidence rates and age-incidence patterns were similar to rates previously published for Caucasian men in Europe and the United States, and were higher than incidence rates published for Asian men living in Asian nations. Prevalence patterns appeared to correspond more closely to patterns observed in developed nations than in Asian nations. PD was associated with markedly increased mortality that appeared to result from effects of both absolute age and disease duration. There was no firm evidence for differences in birth cohort risks of PD. These data may have implications for maturational and environmental theories of PD etiology.

Entities:  

Mesh:

Year:  1996        PMID: 8780088     DOI: 10.1212/wnl.46.4.1044

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Authors:  M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

3.  Estimated life expectancy of Parkinson's patients compared with the UK population.

Authors:  Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

4.  Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors:  Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2017-06-07       Impact factor: 10.338

5.  Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.

Authors:  G Webster Ross; John E Duda; Robert D Abbott; Edo Pellizzari; Helen Petrovitch; Diane B Miller; James P O'Callaghan; Caroline M Tanner; Joseph V Noorigian; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Mov Disord       Date:  2012-09-13       Impact factor: 10.338

6.  Personality and reported quality of life in Parkinson's disease.

Authors:  Gregory M Pontone; Zoltan Mari; Kate Perepezko; Howard D Weiss; Susan S Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

Review 7.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

8.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

9.  Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Authors:  Jordan J Elm
Journal:  Mov Disord       Date:  2012-10       Impact factor: 10.338

10.  Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Authors:  Joshua M Milber; Joseph V Noorigian; James F Morley; Helen Petrovitch; Lon White; G Webster Ross; John E Duda
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.